Nicox S.A. continues to advance its ophthalmic therapies through innovative treatments and strategic partnerships, despite market fluctuations.

Nicox S.A. is a French biotechnology company focused on researching and developing innovative ophthalmic therapies for various eye diseases, with a diverse product pipeline and collaborations with major pharmaceutical companies.